Drugs Containing Excipient (Inactive Ingredient) DODECYLPHOSPHOCHOLINE

✉ Email this page to a colleague

Branded drugs containing DODECYLPHOSPHOCHOLINE excipient, and estimated key patent expiration / generic entry dates

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Eli Lilly and Company	BAQSIMI	glucagon	0002-6145	DODECYLPHOSPHOCHOLINE
Amphastar Pharmaceuticals Inc	BAQSIMI	glucagon	0548-8351	DODECYLPHOSPHOCHOLINE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Generic drugs containing DODECYLPHOSPHOCHOLINE excipient

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Eli Lilly and Company	glucagon	0002-6145	DODECYLPHOSPHOCHOLINE
Amphastar Pharmaceuticals Inc	glucagon	0548-8351	DODECYLPHOSPHOCHOLINE
>Company	>Ingredient	>NDC	>Excipient

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.